Elsevier, the information analytics business specialising in science and health, has announced the launch of a new annual Continuity publication. The series, Advances in Molecular Pathology, offers articles that explore the state-of-the-art developments in molecular testing. Advances in Molecular Pathology is the latest addition to the growing Elsevier Advances family. The series is aimed at practicing pathologists and other clinicians who want to learn more about how molecular diagnostics can positively impact patient care and improve patient outcomes.
Advances in Molecular Pathology provides readers with an in-depth review of the latest clinical advancements in seven subspecialty areas - Genetics, Hematopathology, Infectious Disease, Pharmacogenomics, Informatics, Solid Tumors, and Identity/HLA. This series will help pathologists stay up-to-date as this field continues to develop and grow at an incredible pace.
Members of a distinguished editorial board - Editor-in-Chief Gregory J. Tsongalis and Section Editors Ahmad N. Abou Tayoun, Kevin Alby, Andrea Ferreira-Gonzalez, Todd W. Kelley, Christopher Korch, Ann M. Moyer, and Jeremy P. Segal - have brought together leading experts to discuss trending topics in molecular pathology.
Brought to you by Scope e-Knowledge Center, a trusted global partner for digital content transformation solutions - Abstracting & Indexing (A&I), Knowledge Modeling (Taxonomies, Thesauri and Ontologies), and Metadata Enrichment & Entity Extraction.
